$61.42 Million in Sales Expected for Aterian, Inc. (NASDAQ:ATER) This Quarter

Equities analysts expect Aterian, Inc. (NASDAQ:ATERGet Rating) to report sales of $61.42 million for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Aterian’s earnings. The lowest sales estimate is $61.10 million and the highest is $61.73 million. Aterian posted sales of $68.19 million during the same quarter last year, which suggests a negative year-over-year growth rate of 9.9%. The firm is expected to report its next quarterly earnings results on Monday, January 1st.

According to Zacks, analysts expect that Aterian will report full year sales of $236.50 million for the current year, with estimates ranging from $236.20 million to $236.79 million. For the next financial year, analysts forecast that the company will post sales of $284.55 million, with estimates ranging from $268.20 million to $300.89 million. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research analysts that cover Aterian.

Aterian (NASDAQ:ATERGet Rating) last released its earnings results on Monday, May 9th. The company reported ($0.25) earnings per share for the quarter, hitting the consensus estimate of ($0.25). Aterian had a negative net margin of 80.79% and a negative return on equity of 33.08%. During the same period in the prior year, the company posted ($0.64) earnings per share.

Several research analysts have recently commented on ATER shares. BTIG Research decreased their price target on shares of Aterian from $9.00 to $5.00 and set a “buy” rating for the company in a report on Wednesday, March 9th. DA Davidson decreased their price target on shares of Aterian from $14.00 to $7.00 in a report on Wednesday, March 9th. Alliance Global Partners reduced their target price on shares of Aterian from $9.00 to $4.50 in a research note on Friday, March 11th. Finally, Zacks Investment Research raised shares of Aterian from a “hold” rating to a “buy” rating and set a $4.50 price target for the company in a research note on Tuesday, May 10th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, Aterian currently has a consensus rating of “Buy” and an average price target of $13.83.

ATER opened at $3.64 on Wednesday. The company has a 50-day moving average of $3.80 and a 200-day moving average of $4.05. The company has a market capitalization of $226.02 million, a P/E ratio of -0.69 and a beta of 1.24. Aterian has a 1-year low of $2.10 and a 1-year high of $21.07.

In other news, insider Yaniv Zion Sarig sold 166,127 shares of the business’s stock in a transaction that occurred on Wednesday, March 23rd. The shares were sold at an average price of $2.68, for a total transaction of $445,220.36. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 4.80% of the stock is owned by insiders.

Hedge funds have recently added to or reduced their stakes in the company. Rockefeller Capital Management L.P. acquired a new stake in shares of Aterian during the third quarter valued at approximately $32,000. Citigroup Inc. increased its stake in Aterian by 96.9% in the 3rd quarter. Citigroup Inc. now owns 4,697 shares of the company’s stock valued at $51,000 after buying an additional 2,312 shares during the period. Rhumbline Advisers increased its stake in Aterian by 37.5% in the 1st quarter. Rhumbline Advisers now owns 22,753 shares of the company’s stock valued at $55,000 after buying an additional 6,205 shares during the period. Virtu Financial LLC acquired a new position in Aterian in the 1st quarter valued at approximately $61,000. Finally, Wells Fargo & Company MN increased its stake in Aterian by 3,180.6% in the 4th quarter. Wells Fargo & Company MN now owns 15,255 shares of the company’s stock valued at $63,000 after buying an additional 14,790 shares during the period. Institutional investors and hedge funds own 17.13% of the company’s stock.

About Aterian (Get Rating)

Aterian, Inc, together with its subsidiaries, operates as a technology-enabled consumer products company in North America and internationally. The company provides Artificial Intelligence Marketplace e-Commerce Engine, a software technology platform, which uses machine learning, natural language processing, and data analytics to design, develop, market, and sell products.

Further Reading

Get a free copy of the Zacks research report on Aterian (ATER)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.